initiated

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 05, 2025 08:00 ET  | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the…

1 month ago

Accademia Vallelunga: the world of Lamborghini fueled by adrenalin and lifestyle

An authentic experience as a professional driver on trackSant’Agata Bolognese, 28 October 2025 – Automobili Lamborghini’s second edition of Accademia…

1 month ago

Xinhua Silk Road: 2025 Chishui River Forum to be held in Maotai Town, Guizhou on Oct. 28

BEIJING, Oct. 28, 2025 /PRNewswire/ -- The 2025 Chishui River Forum will be held in the town of Maotai in…

1 month ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

4 months ago

Premier Health Announces a Strategic Review Process to Enhance Shareholder Value

MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company” or “Premier Health”), a…

6 months ago